Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 50Prostatic Neoplasms 44Multiple Myeloma 22Neoplasm Metastasis 17Osteoporosis 14Pain 11Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasms, Plasma Cell 5Lung Neoplasms 5Bone Diseases, Metabolic 5Fractures, Bone 4Bone Diseases 4Lymphoma 3Carcinoma, Renal Cell 3Bone Neoplasms 3Spinal Cord Compression 2Ovarian Neoplasms 2Osteosarcoma 2Neuroblastoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Renal Insufficiency 1Recurrence 1Pleural Effusion, Malignant 1

Interventions

Zoledronic Acid 1Trastuzumab 1Sentinel Lymph Node Biopsy 1Radiofrequency Ablation 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Micrometastasis × Zoledronic Acid × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡